Our first of two articles, published in PME, discusses how measuring platelet function could improve drug discovery, drug development and clinical trials.
The cost of drug development, from discovery to approval for use, is in the billions and rising, often due to high failure rates. Platelets, known for their roles in thrombosis and haemostasis, also play vital roles in immunity, inflammation, cancer metastasis, and neurodegenerative disorders, including Alzheimer’s.
PLANA, our platelet function assay, provides in-depth analysis for use in:
- Drug discovery and drug development to select drug assets that have high efficacy and low off-target effects
- Clinical trials – mitigate identification of adverse events in larger patient groups
The PME article discusses how this new technology will enable patient stratification and simplify and de-risk clinical trials.
Read full article: https://pme.pmlive.com/collections/pme-october-2025/pme-oct-2025-a-new-advent-of-clinical-pathway-management?fullscreen=false
